Treatment of pediatric migraine headaches: A randomized, double-blind trial of prochlorperazine versus ketorolac

被引:97
作者
Brousseau, DC
Duffy, SJ
Anderson, AC
Linakis, JG
机构
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Brown Univ, Dept Pediat, Providence, RI 02912 USA
[3] Brown Univ, Sect Emergency Med, Providence, RI 02912 USA
关键词
D O I
10.1016/S0196-0644(03)00716-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: We compare the effectiveness of intravenous ketorolac and intravenous prochlorperazine in the treatment of pediatric migraine headaches. Methods: We performed a prospective, randomized, double-blind clinical trial in 2 pediatric emergency departments (EDs) within children's hospitals. Children aged 5 to 18 years presenting to the ED with migraine headaches were eligible for the study. Contraindications to either medication or the inability to complete the pain score resulted in exclusion. Children were randomized to receive intravenous ketorolac (0.5 mg/kg; maximum 30 mg) or intravenous prochlorperazine (0.15 mg/kg; maximum 10 mg). All children also received a normal saline solution bolus. Successful treatment was defined as a 50% or greater reduction in the Nine Faces Pain Scale score at 60 I minutes. If a less than 50% improvement occurred by 60 minutes, the child received the other medication. Forty-eight-hour follow-up telephone calls were made to each family to assess recurrence and late side effects. Results: Sixty-two children were enrolled: 33 initially received prochlorperazine, and 29 initially received ketorolac. By 60 minutes, 16 (55.2%) of 29 of those who received ketorolac and 28 (84.8%) of 33 of those who received prochlorperazine were successfully treated (difference=30%; 95% confidence interval [Cl] 8% to 52%). Fifty-six (93.3%) of the 60 children who completed the study were successfully treated by the study's conclusion. Approximately 30% of each group had a recurrence of some headache symptoms. Only 2 children reported side effects, both mild and self-limited. Conclusion: In children, intravenous prochlorperazine is superior to intravenous ketorolac in the acute treatment of migraine headaches.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 20 条
[1]   Migraine and headache in childhood and adolescence [J].
Annequin, D ;
Tourniaire, B ;
Massiou, H .
PEDIATRIC CLINICS OF NORTH AMERICA, 2000, 47 (03) :617-+
[2]  
[Anonymous], ADV PAIN RES THERAPY
[3]   An epidemiologic study of headache among children and adolescents of southern Brazil [J].
Barea, LM ;
Tannhauser, M ;
Rotta, NT .
CEPHALALGIA, 1996, 16 (08) :545-549
[4]   MIGRAINE IN CHILDHOOD AND ITS PROGNOSIS [J].
BILLE, B .
CEPHALALGIA, 1981, 1 (02) :71-75
[5]   Emergency department management of pediatric migraine [J].
Bulloch, B ;
Tenenbein, M .
PEDIATRIC EMERGENCY CARE, 2000, 16 (03) :196-201
[6]   RANDOMIZED, PLACEBO-CONTROLLED EVALUATION OF PROCHLORPERAZINE VERSUS METOCLOPRAMIDE FOR EMERGENCY DEPARTMENT TREATMENT OF MIGRAINE HEADACHE [J].
COPPOLA, M ;
YEALY, DM ;
LEIBOLD, RA .
ANNALS OF EMERGENCY MEDICINE, 1995, 26 (05) :541-546
[7]   KETOROLAC VERSUS MEPERIDINE-PLUS-PROMETHAZINE TREATMENT OF MIGRAINE HEADACHE - EVALUATIONS BY PATIENTS [J].
DAVIS, CP ;
TORRE, PR ;
WILLIAMS, C ;
GRAY, C ;
BARRETT, K ;
KRUCKE, G ;
PEAKE, D ;
BASS, B .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1995, 13 (02) :146-150
[8]   KETOROLAC VERSUS MEPERIDINE AND HYDROXYZINE IN THE TREATMENT OF ACUTE MIGRAINE HEADACHE - A RANDOMIZED, PROSPECTIVE, DOUBLE-BLIND TRIAL [J].
DUARTE, C ;
DUNAWAY, F ;
TURNER, L ;
ALDAG, J ;
FREDERICK, R .
ANNALS OF EMERGENCY MEDICINE, 1992, 21 (09) :1116-1121
[9]  
Ducharme J, 1998, ACAD EMERG MED, V5, P899
[10]   Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study [J].
Hamalainen, ML ;
Hoppu, K ;
Valkeila, E ;
Santavuori, P .
NEUROLOGY, 1997, 48 (01) :103-107